Sector › Medicine
Press Releases
Cambridge Isotope Laboratories, Inc. 在 2025 年法蘭克福國際製藥原料展（CPhI Frankfurt 2025）推出 ISOAPI-D —— 去氘試劑的新標準，推動製藥創新
Cambridge Isotope Laboratories, Inc
Oct 27, 2025 21:00 HKT/SGT
Cambridge Isotope Laboratories, Inc. Unveils ISOAPI-D - a New Standard in Deuterated Reagents for Pharmaceutical Innovation - at CPhI Frankfurt 2025
Cambridge Isotope Laboratories, Inc
Oct 27, 2025 21:00 HKT/SGT
Cambridge Isotope Laboratories, Inc. and Chemtatva Chiral Solutions Pvt. Ltd. to Establish Cambridge Isotope Laboratories, Pvt. Ltd. in Hyderabad, India
Cambridge Isotope Laboratories, Inc
Oct 27, 2025 20:45 HKT/SGT
Cambridge Isotope Laboratories, Inc. 與 Chemtatva Chiral Solutions Pvt. Ltd. 將在印度海得拉巴（Hyderabad）成立 Cambridge Isotope Laboratories, Pvt. Ltd.
Cambridge Isotope Laboratories, Inc
Oct 27, 2025 20:45 HKT/SGT
康哲药业（867.HK; 8A8.SG）签订眼科药物诺适得(R)与倍优适(R)经销协议
China Medical System Holdings Limited
Oct 27, 2025 18:29 HKT/SGT
Health Canada Grants Authorization for "LEQEMBI(R)" (lecanemab) for the Treatment of Early Alzheimer's Disease
Eisai
Oct 27, 2025 13:23 HKT/SGT
FIG, Fujitsu, Acer Medical collaborate to develop health-promoting insurance concept to support preventative care in aging societies
Fujitsu Ltd
Oct 24, 2025 15:52 HKT/SGT
Olympus Launches New Surgical Energy Device for Hemostatic Cutting and Vessel Sealing
Olympus
Oct 21, 2025 22:00 HKT/SGT
Indonesia's Legacy in the Global Vaccine Landscape: Bio Farma and DCVMN Strengthen Health Resilience through Global Partnership
PT Bio Farma (Persero)
Oct 21, 2025 15:45 HKT/SGT
Olympus: "Feasibility study on the development of Japanese digitalized endoscopy infection control systems in India" Selected for METI's FY2024 Supplementary "Global South Future-Oriented Co-Creation Subsidy Program (Small-Scale Demonstration / Feasibility Study Project)"
Olympus
Oct 21, 2025 10:00 HKT/SGT
Owkin Launches K Pro: The First Agentic AI Co-Pilot for Biopharma Powered by Biological Reasoning Models
Owkin
Oct 16, 2025 13:00 HKT/SGT
Everest Medicines Announces First Patient Enrolled in a Global Multi-Center Phase I Clinical Trial of Tumor-Associated Antigen Cancer Vaccine EVM14
Everest Medicines Limited
Oct 14, 2025 17:38 HKT/SGT